Skip to Main Content

Paper Details

No Difference in Penetrance between Truncating and Missense/Aberrant Splicing Pathogenic Variants in <i>MLH1</i> and <i>MSH2</i>: A Prospective Lynch Syndrome Database Study.
J Clin Med
11
2021
CRC, Lynch Syndrome, Lynch syndrome, MLH1, MLH1 and MSH2 genes, MMR, MSH2, MSH2 genes, cancer, cancers, colorectal, colorectal cancer, endometrial cancers, gene, hereditary cancer, mismatch repair, mismatch repair (MMR) genes, missense, path, path_
Author NameAffiliation
David J Burn
David J BurnSt Mark's Hospital
David J BurnNewcastle University
Sigve NakkenInstitute of Cancer Research, The Norwegian Radium Hospital
Sigve NakkenUniversity of Oslo
Eivind HovigInstitute of Cancer Research, The Norwegian Radium Hospital
Eivind HovigUniversity of Oslo
Graham G GilesThe University of Melbourne
Noralane M LindorMayo Clinic Arizona
Noralane M LindorMayo Clinic Arizona
Steven GallingerLunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto
Loic Le MarchandCancer Center, University of Hawaii
Stephen N ThibodeauMayo Clinic
  • 1 - 13

Datasets

Release 1.2